Increased abundance of Cbl E3 ligases alters PDGFR signaling in recessive dystrophic epidermolysis bullosa

Matrix Biol. 2021 Sep:103-104:58-73. doi: 10.1016/j.matbio.2021.10.004. Epub 2021 Oct 24.

Abstract

In recessive dystrophic epidermolysis bullosa (RDEB), loss of collagen VII, the main component of anchoring fibrils critical for epidermal-dermal cohesion, affects several intracellular signaling pathways and leads to impaired wound healing and fibrosis. In skin fibroblasts, wound healing is also affected by platelet-derived growth factor receptor (PDGFR) signaling. To study a potential effect of loss of collagen VII on PDGFR signaling we performed unbiased disease phosphoproteomics. Whereas RDEB fibroblasts exhibited an overall weaker response to PDGF, Cbl E3 ubiquitin ligases, negative regulators of growth factor signaling, were stronger phosphorylated. This increase in phosphorylation was linked to higher Cbl mRNA and protein levels due to increased TGFβ signaling in RDEB. In turn, increased Cbl levels led to increased PDGFR ubiquitination, internalization, and degradation negatively affecting MAPK and AKT downstream signaling pathways. Thus, our results indicate that elevated TGFβ signaling leads to an attenuated response to growth factors, which contributes to impaired dermal wound healing in RDEB.

Keywords: CBL; Fibroblast; Growth factor; Mass spectrometry; PDGFR; Phosphoproteomics; Receptor tyrosine kinase; Tyrosine phosphorylation; Ubiquitination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Collagen Type VII
  • Epidermolysis Bullosa Dystrophica* / genetics
  • Humans
  • Receptors, Platelet-Derived Growth Factor / genetics
  • Ubiquitin-Protein Ligases / genetics
  • Wound Healing

Substances

  • Collagen Type VII
  • Ubiquitin-Protein Ligases
  • Receptors, Platelet-Derived Growth Factor